Originally published June 9 2005
New breath test reduces need for steroids in asthma treatment
by Mike Adams, the Health Ranger, NaturalNews Editor
Half of 94 asthma patients reduced their use of steroid inhalers by 40 percent when their breathing was tested by a new machine that measures exhaled nitric oxide, a study by researchers at New Zealand's Otago University found. The other half relied on doctor's prescriptions based on their described symptoms. The machines, which have been available since $1998 cost about $5,000. The president of Asthma New Zealand, Allen Liang, said the breath-testing method was useful but the cost of each test (about $80) could prove to be prohibitive.
Asthma patients were able to reduce their inhaled steroid drugs by a net 40 per cent when their dosages were tailored using a new type of breath test.
Doctors at present adjust patients' intake of drugs such as Flixotide - which prevent asthma breathlessness and wheezing - mainly based on their reports of symptoms.
But the breath-testing machine, which measures exhaled nitric oxide, has proven more effective, say Otago University researchers.
The results of the study, the first to show the machine can be used to improve asthma care, are published today in a leading American journal, the New England Journal of Medicine.
They reduce with inhaled steroid treatment, but rise again when asthma worsens.
By measuring nitric oxide, the machine assesses inflammation in the breathing tubes of the lungs, allowing doctors to adjust the dosage of inhaled steroid.
"Our study showed that we can use nitric oxide measurements to take some of the guesswork out of deciding how much treatment to give patients with asthma," said Professor Taylor.
"In some cases, using nitric oxide results meant that the treatment dose could be reduced substantially, in some cases to almost zero.
The machines, available since 1998, had reduced in price, now costing about US$5000 ($7059).
Professor Taylor said all public hospitals ought to have one, but only several did - including two in Auckland hospitals.
He said that inhaled steroids were safe, but carried a degree of side-effect risk at high doses, over 1000 mcg a day of Flixotide or its equivalents.
The president of Asthma New Zealand, Allen Liang, said the breath-testing method was useful but the cost of administering each test may prove prohibitive.
Dr Wong said research showed that people taking steroids through puffers had a very small chance of experiencing bone thinning, or osteoporosis.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml